Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|April 5, 2018
Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by AncestryThomas P Slavin, Lily R Van Tongeren, Carolyn E Behrendt, et al.
The Prostate|March 3, 2022
Hereditary cancer risk assessment and genetic testing in the community urology practice settingNeal D Shore, Lauren Lenz, Elizabeth S Cogan, et al.
Genes, Chromosomes & Cancer|May 24, 2023
The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencingMelanie A Jones, Kirsten M Timms, Shanell Hatcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast CancerAnastasia Constantinidou, Yiola Marcou, Michael S Toss, et al.
Cancer|July 6, 2021
Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health InitiativeAllison W Kurian, Elisha Hughes, Timothy Simmons, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
Familial Cancer|July 9, 2017
The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genesThomas P Slavin, Susan L Neuhausen, Bita Nehoray, et al.
Science Translational Medicine|August 9, 2019
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancerBradon R McDonald, Tania Contente-Cuomo, Stephen-John Sammut, et al.
Cancer|April 15, 2021
Germline mutations and age at onset of lung adenocarcinomaKaren L Reckamp, Carolyn E Behrendt, Thomas P Slavin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2018
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA SequencingThomas P Slavin, Kimberly C Banks, Darya Chudova, et al.
Pageof 9